drug

ABBV-706

1 story · latest Oct 29, 2026

Follow ABBV-706. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: Investigational
Trials: 2 registered trials in coverage

Relationships

Developed by AbbVie

Timeline

AbbVie posts KEEPsAKE 2 update; registers pediatric vitiligo and real-world MIRV studies

Oct 29Weekly roundup, 7 itemsABBV-706 ABBV-722Updated

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.